Clarivate (NYSE:CLVT) Stock: Insider Bar Veinstein Sells 254,558 Shares

Clarivate PLC (NYSE:CLVT – Get Free Report) insider Bar Veinstein sold 254,558 shares of the stock in a transaction dated Wednesday, November 18th. The shares were sold at an average price of $2.13, for a total value of $542,208.54. Following the completion of the transaction, the insider directly owned 1,008,458 shares of the company’s stock, valued at $2,148,015.54. This represents a 20.15% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Clarivate Stock Down 2.0%

Shares of Clarivate stock opened at $2.01 on Friday. The business has a 50-day moving average price of $1.87 and a 200 day moving average price of $2.18. Clarivate PLC has a fifty-two week low of $1.42 and a fifty-two week high of $3.87. The firm has a market cap of $1.29 billion, a P/E ratio of -3.30 and a beta of 1.38. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.92.

Clarivate (NYSE:CLVT – Get Free Report) last issued its earnings results on Wednesday, November 4th. The company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.03. The company had revenue of $481.60 million for the quarter, compared to analysts’ expectations of $566.77 million. Clarivate had a negative net margin of 17.02% and a positive return on equity of 9.84%. The firm’s revenue was down 22.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.18 earnings per share. On average, sell-side analysts forecast that Clarivate PLC will post 0.67 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of CLVT. FreeGulliver LLC bought a new position in shares of Clarivate in the first quarter valued at approximately $30,000. Headlands Technologies LLC bought a new stake in shares of Clarivate in the 3rd quarter valued at approximately $30,000. Commonwealth Equity Services LLC acquired a new position in Clarivate during the third quarter worth $30,000. Principal Financial Group Inc. acquired a new stake in shares of Clarivate during the 1st quarter worth about $32,000. Finally, Parallel Advisors LLC raised its stake in shares of Clarivate by 94.2% in the first quarter. Parallel Advisors LLC now owns 13,786 shares of the company’s stock valued at $35,000 after acquiring an additional 6,687 shares during the last quarter. 85.72% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Wall Street Zen lowered shares of Clarivate from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Jefferies Financial Group restated a “hold” rating and set a $2.25 price target on shares of Clarivate in a research report on Thursday, November 5th. Morgan Stanley initiated coverage on shares of Clarivate in a report on Friday, October 30th. They issued an “underweight” rating and a $1.50 price objective for the company. William Blair lowered shares of Clarivate to a “market perform” rating in a research note on Thursday, October 15th. Finally, Stifel Nicolaus dropped their price objective on Clarivate from $6.00 to $5.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. One investment analyst has rated the stock with a Buy rating, five have issued a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average target price of $2.65.

Check Out Our Latest Report on CLVT

Clarivate Company Profile

(Get Free Report)

Clarivate provides information, analytics and workflow tools to customers in academia and government, life sciences and healthcare, and intellectual property. Its services help organizations find and analyze research, assess scientific and commercial developments, and manage patents, trademarks and other intellectual property. Its products include Web of Science and ProQuest research resources, Cortellis life sciences intelligence, and intellectual property databases and services such as Derwent.

Featured Articles

Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.